Showing results (221-230 of 5,165) with videos related to

Sort By:
Pageof 517
Current Oncology (Toronto, Ont.)|July 25, 2022
Breast Cancer Patients: Who Would Benefit from Neoadjuvant Chemotherapies?Liqin Yao, Gang Jia, Lingeng Lu, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Appraising Adjuvant Endocrine Therapy in Hormone Receptor Positive HER2-Negative Breast Cancer-A Literature ReviewDanilo Giffoni de Mello Morais Mata, Carlos Amir Carmona, Andrea Eisen, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Management of Myelofibrosis during Treatment with Ruxolitinib: A Real-World Perspective in Case of Resistance and/or IntoleranceMassimo Breccia, Francesca Palandri, Paola Guglielmelli, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Emerging Biomarker-Guided Therapies in Prostate CancerJasna E Deluce, Luisa Cardenas, Aly-Khan Lalani, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Actinic Keratoses (AK): An Exploratory Questionnaire-Based Study of Patients' Illness PerceptionsDimitrios Sgouros, Adamantia Milia-Argyti, Dimitrios K Arvanitis, et al.
Current Oncology (Toronto, Ont.)|November 24, 2023
Iron Surveillance and Management in Gastro-Intestinal Oncology Patients: A National Physician SurveyEmilie S Richard, Adriyan Hrycyshyn, Noor Salman, et al.
Current Oncology (Toronto, Ont.)|November 24, 2023
Low-Grade Pseudomyxoma Peritonei Behaving as a High-Grade Disease: A Case Series and Literature ReviewPetros Bangeas, Dimitrios Kyziridis, Apostolos Kalakonas, et al.
Current Oncology (Toronto, Ont.)|November 24, 2023
Sharing Experience with Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors in Lung Cancer: An Italian Expert Panel DiscussionCesare Gridelli, Marcello Tiseo, Diego Luigi Cortinovis, et al.
Current Oncology (Toronto, Ont.)|November 24, 2023
Estrogen-Receptor-Low-Positive Breast Cancer: Pathological and Clinical PerspectivesChristina Panagiotis Malainou, Nikolina Stachika, Aikaterini Konstantina Damianou, et al.
Pageof 517